Skip to content
Home/Companies/Biotech/Mahzi Therapeutics

Mahzi Therapeutics

Biotech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Mahzi Therapeutics?

Mahzi Therapeutics is an American Biotech company, currently owned by HealthCap since 2020.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VII · 2016 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from HealthCap VII

Other portfolio companies in the same fund.

Priothera Ltd.
Active
BiotechIreland· 2020
SynOx Therapeutics Ltd
Active
BiotechIreland· 2020
Carisma Therapeutics
Exited 2023
BiotechUS· 2018
to Sesen Bio, Inc.
InCarda Therapeutics Inc.
Active
BiotechUS· 2018
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2018
Precirix
Active
BiotechBelgium· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Mahzi Therapeutics?

Mahzi Therapeutics is currently owned by HealthCap, through HealthCap VII, since 2020.

When did HealthCap acquire Mahzi Therapeutics?

HealthCap acquired Mahzi Therapeutics in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue